For biopharma communications teams
Know who to brief, and what your outreach may be missing.
Biopharma-specific intelligence connecting relevant intermediaries, emerging AI-search sources and practical engagement routes before your next milestone. For each therapy area, GPS maps who to brief across four audiences and reads which sources a search-grounded assistant returns on the area's questions. Every row says what was confirmed on its own page and when, and carries the way to engage.
Communications has always worked through the intermediary. Now one of them reads for itself, and on patient and clinician questions it returns different sources from the ones on most lists.
Read on the page, dated, never estimated. GPS shows who holds the answer; it never claims to change it.
The gap
Your outreach list and the AI-search sources are two different lists.
Every Sunday GPS asks the same 24 patient and clinician questions across its therapy areas, one grounded web search each, and records every source that comes back. On 1 November 2026:
- 13 of 157Only 13 of the 157 web hosts returned in our November 1 search panel were represented on our GPS lists (underlying audit).
- 0 of 40source positions on the rare disease questions went to outlets on the rare disease list, a fourth week running.
- 0guideline, journal or regulator sources in 40 positions on the four obesity questions, a fourth week running.
Each reading shows what one search-grounded assistant had available to read for a question on that date. It is not what any assistant told a user, one reading is not a trend, and it describes our panel and our lists, not every AI or everyone’s media list.
Patient and clinician treatment questions naturally surface different sources from pharma-industry news. The outlets comms teams pitch are still worth pitching. The opportunity is to broaden the plan, and a contact list alone does not show which part is missing.
The map
Who to brief, by audience, area by area.
For each therapy area, 30 to 45 people and outlets in four audience lanes, plus the embargo routes and the rows to handle with care.
HCPs & clinical science
Specialist trade press, clinician-hosted podcasts, society channels and journals.
Patients, caregivers & public
National consumer press, patient advocates, creators and health portals. Advocates through community norms, never a cold pitch.
Payers, policy & access
Policy and pricing reporters, managed-care trade, employer-benefits writers and independent policy research.
Business & investors
Biopharma business newsrooms and recurring trackers.
What AI reads
Who holds the answer, and who is missing.
- The same fixed questions for each area, every Sunday: questions a patient or clinician might ask, one grounded web search each.
- Every source read, and the people on each page named as the page prints them.
- The outlets on your map that are absent from the answers.
- The guideline, journal and regulator sources that are missing.
- The sites that should not be there: off-topic pages and development sites holding a place in a health answer.
- How to engage each source that holds the answer: an accuracy correction, a partnership, a medical affairs conversation, earned media.
Kept current
Current, and honest about it.
- Verified
- Checked in the last 30 days: title read on the person's or outlet's own page, a dated output on this area within 60 days, and a contact route seen.
- Partial
- Checked in the last 30 days, with one of the three not confirmed. The row says which.
- On record
- Not checked from its own page in the last 30 days. Check before use.
- Hold
- Do not approach until the open question on the row is resolved.
Ageing rows are re-read from their own pages twice a month, and a row nobody has checked for 30 days says so. Contact routes are copied as the person or publisher shows them; masked emails stay masked. Audience figures are self-reported and dated. Commercial conflicts are recorded when observed, never inferred.
Areas
Five therapy areas at launch.
- Obesity & Metabolic
- Oncology
- Immunology
- Cardiology
- Rare Disease
Pharma and biotech first, US-weighted. Medtech needs its own map and comes later.
Your next milestone
Start with one therapy area.
Bring the readout, approval, congress or launch you are preparing for. GPS connects the people to brief, the sources behind AI search and the engagement routes to consider.
Discuss a GPS pilotHow teams buy it
By the area, beside your media database.
GPS Milestone Watch Pilot
A four-week paid pilot for one therapy area and one named milestone. One map of the people and outlets to brief, plus weekly updates over 30 days based on 16 total AI-search scans. Use public questions and web sources to see the gaps before your next readout, congress or launch.
GPS in Brand Workspace
Weekly GPS is included in the annual CommsRx Brand Workspace, alongside Ally, CAMS and Morning Desk. Carry the map into your team’s strategy, messaging and materials as the work continues across milestones.
GPS Agency
Annual GPS access for agency client teams. Co-branded or white-label delivery is available under a written partner agreement; each client’s work stays separate.
Start with a founder-led walkthrough of your area and milestone. Pilot and annual pricing on request.
When you need the wider platform
Start with GPS. Continue in CommsRx.
GPS stands on its own, private milestone slice included. When you want the wider platform, CommsRx carries the map into strategy, messaging, materials and execution with Ally. Your GPS rows carry across; the hand-off is one way.
Questions
Frequently asked questions.
What is GPS?
GPS is biopharma-specific intelligence for communications teams, from Signal Fidelity Group. For each therapy area it maps the people and outlets to brief across four audiences, with how to approach each one, and reads the sources a search-grounded assistant returns on a fixed set of patient and clinician questions about the area. Every row says what was confirmed on its own page, and when.
Who is GPS for?
Product, franchise and corporate communications leads at pharma and biotech companies, media relations leads, and the healthcare PR agencies that work with them. It is built for the weeks before a moment: a readout, an approval or label change, a congress or a launch.
How is GPS different from a media database?
A media database lists everyone on every beat. GPS is a short map for one therapy area: 30 to 45 people and outlets across four audiences, each dated with what was confirmed, how to engage and whether it was returned in what AI reads. Most teams keep their database and use GPS beside it; the rows export to Excel and CSV.
What does “what AI reads” mean?
Every Sunday GPS runs the same questions for each area, one grounded web search each, and reads every source that comes back. A source listed is in what a search-grounded assistant has available to read for that question on that date. It is not what any assistant told a user, and one reading is not a trend.
Can GPS change what AI says about our product?
No, and we do not claim to. GPS shows who holds the answer and the routes a communications team can properly take: an accuracy correction, a partnership, a medical affairs conversation, earned media.
How current is GPS?
Every row shows the date it was last checked and what was confirmed. Ageing rows are re-read from their own pages twice a month, and a row nobody has checked for 30 days says so.
Which therapy areas does GPS cover?
Five at launch: Obesity & Metabolic, Oncology, Immunology, Cardiology and Rare Disease. Pharma and biotech first, US-weighted. Medtech needs its own map and comes later.
Can we see our own milestone's questions?
Yes, as a bounded, private slice: for a named milestone, up to four of your own questions are read on the same Sunday cadence as the panel, for your team only. Your milestone questions are kept separate from the fixed public panel, and are reported the same way: what a search-grounded assistant had available to read, never what it answered.
What does the GPS pilot include?
The GPS Milestone Watch Pilot covers one therapy-area map and weekly updates over 30 days, based on 16 total AI-search scans. It is a four-week paid engagement using public questions and web sources. Pricing is available in a founder-led walkthrough. Weekly GPS is also included in the annual CommsRx Brand Workspace, with a separate GPS Agency option for agency client teams.
What do you need from us?
Nothing to upload. Name the therapy area and the milestone you are preparing for, and the pilot starts there.
How do you handle contact details and conflicts?
Contact routes are copied as the person or publisher shows them, and emails a page masks stay masked. Commercial conflicts are recorded when observed, never inferred, and rows that need one go to compliance before any brief. Anyone listed in GPS can ask us to correct or remove their entry at help@signalfidelitygroup.com.
Is GPS part of CommsRx?
GPS and CommsRx both come from Signal Fidelity Group. GPS works on its own, including the private slice for your milestone. CommsRx is the wider platform: strategy, messaging, materials and execution with Ally, with the map carried into each. A team that starts in GPS can carry its rows into CommsRx; the hand-off is one way.
Who built GPS?
GPS was built by Abhi Basu, founder of Signal Fidelity Group. He started in 2005 as an assistant account executive and later worked as a global communications executive at the largest healthcare company in the world. He built GPS so the list a team builds before every milestone can be checked against where its audiences actually look.
See your area
Name your area and your next milestone. See your map.
A four-week Milestone Watch Pilot: one therapy-area map and weekly updates over 30 days, based on 16 total AI-search scans. Public questions and web sources; nothing to upload.